Alnylam Pharmaceuticals
ALNY
#446
Rank
NZ$90.44 B
Marketcap
NZ$684.58
Share price
-3.65%
Change (1 day)
61.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company